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Abstract: Antibody engineering has allowed for the rapid generation of binding agents 
against virtually any antigen of interest, predominantly for therapeutic applications. 
Considerably less attention has been given to the development of diagnostic reagents and 
biosensors using engineered antibodies. Recently, we produced a novel pentavalent 
bispecific antibody (i.e., decabody) by pentamerizing two single-domain antibodies (sdAbs) 
through the verotoxin B subunit (VTB) and found both fusion partners to be functional. 
Using a similar approach, we have engineered a bispecific pentameric fusion protein 
consisting of five sdAbs and five cellulose-binding modules (CBMs) linked via VTB. To 
find an optimal design format, we constructed six bispecific pentamers consisting of three 
different CBMs, fused to the Staphylococcus aureus-specific human sdAb HVHP428, in 
both orientations. One bispecific pentamer, containing an N-terminal CBM9 and C-terminal 
HVHP428, was soluble, non-aggregating, and did not degrade upon storage at 4 ºC for over 
six months. This molecule was dually functional as it bound to cellulose-based filters as well 
as S. aureus cells. When impregnated in cellulose filters, the bispecific pentamer recognized 
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S. aureus cells in a flow-through detection assay. The ability of pentamerized CBMs to bind 
cellulose may form the basis of an immobilization platform for multivalent display of high-
avidity binding reagents on cellulosic filters for sensing of pathogens, biomarkers and 
environmental pollutants.  
Keywords:  single-domain antibody; cellulose-binding module; bispecific; pentamer; 
Staphylococcus aureus; pathogen detection 
 
1. Introduction  
 
Single-domain antibodies (sdAbs), derived from the variable heavy (VH) and variable light (VL) 
domains of immunoglobulin G (IgG) [1], from the variable domain (i.e., VHH) of Camelidae species’ 
heavy-chain IgG [2,3] and more recently from the variable domain of shark immunoglobulin new 
antigen receptor (IgNAR) antibodies [4] have several characteristics that make them potential 
candidates for diagnostic and therapeutic applications [5,6]. These characteristics include: small size 
(14-15 kDa) and single domain nature [7], high solubility, high thermal and proteolytic stability [8-10], 
high target affinity (nM - pM range) [11], accessibility to cryptic target-antigens (Ag) [12] and high 
yields in bacterial and yeast expression systems [13,14]. The physical robustness and relatively low 
production cost of sdAbs make them logical antibody-based molecules for incorporation into 
immunosensors. 
The generation of bispecific molecules, such as bispecific antibodies (bsAbs) which bind two 
distinct epitopes, has been one strategy to enhance the therapeutic potency of sdAbs and other 
antibody fragments such as Fabs (fragments antigen binding) and scFvs (single-chain fragments 
variable; reviewed in Holliger and Hudson [15]). Traditionally, bsAbs have been produced for the 
purpose of: (i) increasing the avidity of an Ab-Ag interaction by fusing two or more Abs which bind 
different epitopes on the same antigen [16] or (ii) activating innate and adaptive immune responses by 
fusing an Ab with specificity for effector cells to a second, target-specific Ab [17]. Other bispecific 
molecules containing antigen-specific antibody fragments fused to fragment crystallizable (Fc) regions 
have also been successfully produced [15]. Few authors, however, have examined the potential of 
bispecific molecules for diagnostic and biosensing applications. By replacing one of the antibodies in a 
bsAb with an immobilization domain, antibodies could conceivably be anchored to solid support 
matrices [6] for the specific capture and/or detection of food-, water-, or blood-borne pathogens, toxins, 
small molecules, or viruses. A molecule in which a sdAb is fused to an anchoring domain combines 
the many advantages of sdAbs, noted above, and the benefits of oriented immobilization of the 
detecting molecule on the biosensor surface. Simple adsorption or random coupling of antibody 
molecules to surfaces results in random orientation of the antibody molecule and can result in steric 
hindrance problems, antibody denaturation and, in the case of physical adsorption, loss of the antibody 
from the sensing surface. Collectively, this could compromise the effective antibody binding density 
and decrease biosensor sensitivity. Sensors 2009, 9                  
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There is a need, particularly in the developing world, for inexpensive sensing devices, for clinical 
and environmental applications, that do not rely on sophisticated instrumentation. Cellulose is an 
attractive support matrix for the development of novel biosensing surfaces because of its chemical and 
physical stability, low cost, low nonspecific affinity for proteins and approval for human and 
therapeutic use [18]. Recently, paper-based microfluidic devices have been shown to perform well as 
low cost analytical systems for colourimetric bioassays [19,20]. In another cost-effective paper-based 
bioassay using gold nanoparticle colourimetric probes, the paper substrate was observed to provide a 
bright background and to protect the DNA-cross-linked nanoparticles used in the assay [21]. 
Cellulose-binding modules (CBMs), originally identified in Trichoderma reesei and Cellulomonas fimi, 
are the non-catalytic domains of cellulases and are responsible for anchoring and concentrating the 
enzymes on insoluble cellulose [22,23]. CBMs have high and specific affinity for a variety of soluble 
and insoluble celluloses, depending on their subfamily of origin 
(http://www.cazy.org/fam/acc_CBM.html). In the past, several CBMs have been fused to biologically 
active molecules such as enzymes, cytokines, and antibodies for various applications (see review by 
Shoseyov  et al. [24]). To make CBM-antibody fusions a practical alternative to the covalent 
immobilization of antibodies for diagnostic applications, near irreversible anchoring of high-affinity 
antibodies is required. One possible approach to achieve this is to increase the avidity of cellulose-
CBM and Ab-Ag interactions simultaneously through the multimerization of both CBM and Ab 
domains. Expression of sdAbs fused to verotoxin (VTB) has permitted the expression and assembly of 
pentameric antibodies with higher avidity and apparent affinities than monomeric versions of the same 
sdAbs [16].  
Recently, a bispecific pentavalent antibody (i.e., decabody) was constructed by inserting the VTB 
gene between two single-domain antibodies capable of binding parathyroid hormone (PTH) [25]. 
Using a similar approach, our goal here was to engineer a pentameric, bispecific molecule that would 
bind cellulose, through five CBMs, and the human pathogen Staphylococcus aureus, through five 
copies of a human sdAb (referred to as HVHP428 [26]), which specifically recognizes cell-surface 
protein A (Figure 1). We designed six bispecific expression cassettes based on three CBM variants 
fused to either the N- or C- terminus of HVHP428 and characterized these fusion proteins. One format, 
consisting of an N-terminal CBM9 fusion (CBM9-VTB-HVHP428), was expressed and purified in 
soluble form from E. coli with only a small fraction prone to degradation. This bispecific pentamer 
was capable of binding to cellulose-based filters through the pentameric CBM and also retained its 
ability to agglutinate S. aureus cells through the pentameric sdAb. Furthermore, cellulose filters 
containing immobilized CBM9-VTB-HVHP428 were capable of detecting S. aureus cells to a limit of 
detection of 10
5 cfu/mL (p = 0.05) when used in a vacuum flow-through assay. 
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Figure 1. Overview of fusion protein construction and characterization. 
  
 
 
2. Materials and Methods 
 
2.1. Cell Lines and Plasmids 
 
All bacterial cloning and expression was conducted in the pVT1 expression vector [25] using 
electrocompetent TG1 Escherichia coli from New England Biolabs (Mississauga, ON, Canada). For 
yeast cloning, constructs were assembled in the pPICZαA vector and expression was conducted in 
Pichia pastoris strain X-33 that was purchased from Invitrogen (Mississauga, ON, Canada). S. aureus 
(ATCC12598) was purchased from American Type Culture Collection (Manassas, VA, USA). 
 
2.2. Cloning and Expression of sdAb-CBM Fusions 
 
The human sdAb HVHP428 [26], which specifically recognizes S. aureus protein A, and three 
cellulose-binding modules: (i) CBM2a [27], (ii) CBM2a(m), a CBM2a mutant devoid of five putative 
N-glycosylation sites [28] and codon-optimized for P. pastoris (JCH, unpublished data), and (iii) 
CBM9 [29], were used. DNA encoding CBM2a and CBM9 were gifts from Dr. C.A. Haynes, 
University of British Columbia. A total of fourteen constructs were assembled with various 
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combinations and orientations of HVHP428, CBM, or both. Of these, ten were expressed in either 
E. coli or P. pastoris. Briefly, CBM and sdAb genes were amplified by PCR and flanked with DNA 
encoding linker sequences and restriction sites BbsI/ApaI or BsiWI/ApaI for N-terminal fusions and 
BspEI/BamHI for C-terminal fusions.  PCR primers for gene amplification and introduction of 
restriction sites for ligation are summarized in Table 1. Three linkers designated L1, L2, and L3, which 
separate the CBM, VTB, and HVHP428 domains, were the same linkers as those used for a clone in a 
previously described bispecific pentamer [25]. Amplified insert DNA was digested with the 
corresponding restriction enzymes and ligated into a similarly digested pVT1 vector. One clone, 
HVHP428-VTB-CBM2a(m), which contained a CBM devoid of the putative N-glycosylation site A-
X-T/S (X = any amino acid except P), was subcloned into the pPICZαA expression vector from pVT1 
and transformed into chemically competent P. pastoris X-33 according to the manufacturer’s 
instructions (Invitrogen). Monospecific and bispecific pentamers were expressed in E. coli as 
described [16]. Protein expression in P. pastoris was induced with 0.5% methanol for four days and 
proteins were purified according to the manufacturer’s instructions (Invitrogen). Expression of 
recombinant proteins was monitored by Western blotting using anti-His6 IgG (GE Healthcare, Baie-
d’Urfé, QC, Canada) for detection (data not shown). 
 
Table 1. Oligonucleotides used in the assembly of expression constructs. 
Construct  Oligonucleotide sequence (5’ Æ 3’, enzyme sites underlined)  RE 
1-For  GTTGCGCAGGCCGTCTTCCAGCTGCAGCTGCAGGAGT  BbsI 
1-Rev  GGAGCCGCCGCCGGGCCCTGAGGAGACGGTGACCA  ApaI 
2-For  GGTGGGTCCGGACAGCTGCAGCTGCAGGAG  BspEI 
2-Rev  AGTTTTTGTTCGGATCCTGAGGAGACGGTGACCA  BamHI 
3-For  GGTGGGTCCGGATCTGGTCCGGCGGGTTGTC  BspEI 
3-Rev  AGTTTTTGTTCGGATCCACCAACGGTACACGGGGCAC  BamHI 
4-For  GGTGGGTCCGGAAGCGGCCCGGCCGGGTG  BspEI 
4-Rev  AGTTTTTGTTCGGATCCGCCGACCGTGCAGGGCGTG  BamHI 
5-For  GGTGGGTCCGGAATGACTAGCGGAATAATGGTAG  BspEI 
5-Rev  AGTTTTTGTTCGGATCCAAAGCTTGATGAGCCTGAGG  BamHI 
6-For  GTTGCGCAGGCCGTCTTCTCTGGTCCGGCGGGTTGTC  BbsI 
6-Rev  GGAGCCGCCGCCGGGCCCACCAACGGTACACGGGGCAC  ApaI 
7-For  GTTGCGCAGGCCGTCTTCAGCGGCCCGGCCGGGTG  BbsI 
7-Rev  GGAGCCGCCGCCGGGCCCGCCGACCGTGCAGGGCGTG  ApaI 
8-For  GGCCGTCTTCGTACGAATGACTAGCGGAATAATGGTAG  BsiWI 
8-Rev  GGAGCCGCCGCCGGGCCCAAAGCTTGATGAGCCTGAG  ApaI 
9-For (pPICZαA)  TTTTGTCTCGAGAAAAGAGAGGCTGAAGCTCAGCTGCAGCTGCAGGAGTCG  XhoI 
9-Rev (pPICZαA)  TTTTGTGTCGACCTATCAATGGTGATGGTGATGGTTCAGATC  SalI 
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2.3. Purification of Recombinant Proteins and Size Exclusion Chromatography 
 
E. coli cells were harvested at 12,000 rpm × 20 min, supernatant removed, and the pellets processed 
by total cell lysis [25]. Soluble fractions were dialyzed into immobilized metal affinity 
chromatography (IMAC) buffer A (10 mM HEPES buffer pH 7.0, 500 mM NaCl), sterile filtered, and 
protein was purified by IMAC using 5 mL HiTrap™ Chelating HP IMAC columns (GE Healthcare), 
under the control of an ÄKTA™-FPLC (GE Healthcare). A step-wise gradient of 500 mM imidazole 
in the above buffer was used for protein elution. Proteins were stored at 4 ºC. Insoluble proteins found 
in inclusion bodies were not processed further. Size exclusion chromatography was performed on all 
purified proteins with a Superdex 200™ column under the control of an ÄKTA™-FPLC, as   
described [25]. For P. pastoris, recombinant proteins were secreted into the culture medium, cells were 
harvested and the clarified supernatant was loaded onto a HiTrap™ IMAC column and eluted as 
described above. 
 
2.4. Microagglutination Assays 
 
A microagglutination assay was performed to determine whether CBM9-VTB-HVHP428 retained 
its ability to bind and agglutinate S. aureus cells. Fifty microlitre aliquots of gamma-irradiated   
S. aureus cells (1 × 10
8 cfu/mL) were added to 96-well microtitre plates. Proteins (CBM9-VTB-
HVHP428, HVHP428-VTB, and HVLP335-VTB [26]) were serially diluted 2-fold in MES buffer 
(30 mM MES pH 6.0, 70 mM NaCl) in 11 wells. The last well contained MES buffer and S. aureus. 
Starting concentrations were 600 nM for HVHP428-VTB, CBM9-VTB-HVHP428, and   
VHLP335-VTB control. After addition of cells and proteins, the mixtures were incubated overnight 
(18 h) at 4 ºC and scored visually for agglutination.  
 
2.5. Cellulose Binding Assays 
 
To determine if CBM9-VTB-HVHP428 binds to cellulose, 2-fold serial dilutions of purified protein 
were spotted onto Whatman No. 5 filter paper (GE Healthcare) starting at 800 nM with a 96-well Bio-
Dot vacuum manifold from Bio-Rad (Hercules, CA, USA). All protein dilutions were prepared in PBS. 
The filter paper was washed 3x with PBS and blocked for 1 h at room temperature with 5% BSA (w/v) 
in PBS. Protein A conjugated with alkaline phosphatase (AP) was purchased from Pierce (Rockford, 
IL, USA) and applied to the paper using the vacuum manifold (100 µL of a 1:5,000 dilution) followed 
by the addition of AP substrate (Bio-Rad) to detect CBM9-VTB-HVHP428 binding. HVHP428-VTB 
was applied to the filter paper with a starting concentration of 800 nM and served as a negative control. 
 
2.6 Detection of S. aureus with CBM9-VTB-HVHP428  
 
Circular cellulose discs (6 mm diameter, 20-25 µm pore size) were prepared from Whatman 
451 filter paper (GE Healthcare) using a standard hole-punch. Discs were pre-wetted with PBS and 
placed in the 96-well Bio-Dot vacuum manifold (Bio-Rad). All experiments were conducted at 20 ºC. 
To “load” the filters, 5 µL of CBM9-VTB-HVHP428 (~200 μg/mL) or 5 μL of VTB-Sensors 2009, 9                  
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HVHP428 (~100 µg/mL) diluted in PBS were applied to the circular cellulose discs without suction, 
incubated for 20 min, and then pulled through under vacuum pressure. “Loaded” and untreated discs 
were blocked with 300 µL of 3% (w/v) skim milk in PBS and washed 3x with 300 µL PBS-0.05% (v/v) 
Tween 20  (PBST). Five microliters of serially diluted gamma-irradiated S. aureus (starting at 
1 × 10
8 cfu/mL) were applied to the cellulose filters without suction, incubated for 30 min, and pulled 
through the filters under vacuum pressure. Discs were washed 3x with PBST, incubated with anti-
protein A-HRP IgG (Invitrogen; 1:5,000 dilution, 20 min incubation), and washed an additional 3x 
with PBST followed by 2x with PBS. For detection of binding, discs were transferred to a 96-well 
microtiter plate, and submersed in 150 µL of peroxidase substrate from Mandel Scientific (Guelph, 
ON, Canada) for 45 min. The reaction was stopped by the addition of 150 µL 10% H2SO4 to each well. 
Discs were removed from the plate and well contents were read at 450 nm using a Bio-Rad plate 
reader. 
 
3. Results  
 
3.1. Expression and Characterization of CBM-sdAb Fusion Proteins 
 
Previously, we reported the assembly of pentameric single-domain antibodies (sdAbs) by fusing a 
parathyroid hormone peptide-specific VHH to the C-terminus of VTB [16] and more recently the 
generation of bispecific pentameric sdAbs (i.e., decabodies) by fusing two sdAbs through the VTB 
gene [25]. The pentameric fusions increased overall apparent affinities towards the parathyroid 
hormone peptide antigen by 10
3 to 10
4 fold [16] and the bispecific pentamer resulted in a molecule 
with ten functional antibodies capable of antigen binding [25]. To develop a platform for immobilizing 
pentameric sdAbs on solid cellulose supports, we produced several cellulose-binding module   
(CBM)–sdAb fusion constructs which contained an internal VTB homopentamer for assembly   
(Figure 2). A total of eight monospecific (i.e., CBM or sdAb) and 6 bispecific (i.e., CBM + sdAb) 
constructs were assembled and characterized based on soluble expression in E. coli, expression yield, 
as well as susceptibility to both aggregation and degradation (Table 2). For all constructs involving 
sdAbs, the anti-S. aureus human sdAb HVHP428 [26] was used. N-terminal fusions of HVHP428 to 
VTB (HVHP428-VTB) were produced as soluble, non-aggregating, monospecific pentamers 
(Figure 3). N-terminal CBM2a-VTB expressed in soluble fractions, whereas N-terminal CBM2a(m)-
VTB was found in inclusion bodies. Conversely, C-terminal VTB-CBM2a(m) was found to be soluble. 
Three bispecific combinations containing C-terminal CBM2a(m), CBM2a, and CBM9 did not express 
at all. One of these fusion proteins, HVHP428-VTB-CBM2a(m) was subcloned into the pPICZαA 
vector and was found to express in P. pastoris, but not explored further. Three other bispecific clones 
containing N-terminal CBMs were found to be soluble when expressed in E. coli and were 
characterized further. Bispecific pentamers containing N-terminal CBM2a or CBM2a(m) were prone 
to aggregation and degraded. However, one bispecific pentamer containing an N-terminal CBM9 
showed no aggregation tendency and only minor degradation (Figure 3), with an expression yield of 
7.8 mg/L of bacterial culture. 
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Figure 2. Assembly of bispecific pentamers. (A) Schematic representation of a bispecific 
pentamer displaying five human sdAbs fused to five CBMs through the verotoxin subunit 
(VTB). (B-D) Schematic representation of the coding sequences assembled and expressed 
in pVT1 (B, C) or pPICZαA (D). 
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Figure 3. Analysis of purified monospecific and bispecific pentamers. (A) SDS-PAGE 
(reducing conditions, ~3 µg protein per lane) demonstrating the stability of purified 
proteins which had been stored at 4 ºC for six months. The reducing conditions separated 
the pentamerized molecules into five single polypeptide chains. The expected masses of 
monospecific HVHP428-VTB and bispecific CBM9-VTB-HVHP428 in an SDS-PAGE gel 
are 24.4 kDa and 45.7 kDa, respectively. (B) Size exclusion chromatography using a 
Superdex 200™ column revealed both HVHP428-VTB and CBM9-VTB-HVHP428 were 
non-aggregating since a single, homogeneous peak was observed for each within the 
expected mass range. The bispecific CBM9-VTB-HVHP428 pentamer eluted later than 
expected. Protein standards are indicated with arrows. 1: thyroglobulin (Mr 669,000); 
2: ferritin  (Mr 440,000); 3: BSA (Mr 67,000); 4: beta-lactoglobulin (Mr 35,000); 
5: ribonuclease A (Mr 13,700). 
   
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 5 10 15 20
0
20
40
60
80
100
120
CBM9-VTB-HVHP428
HVHP428-VTB
1 2
Elution Volume (ml)
A
2
8
0
 
(
m
A
U
)
3
4
5
CBM9-VTB-HVHP428 
HVHP428-VTB 
SDS-PAGE 
(reducing) 
50 kDa  
40 kDa  
25 kDa  
20 kDa  
(A) 
(B) Sensors 2009, 9                  
 
 
5360
Table 2. Summary of constructs, expression profiles, and purified proteins. 
Construct (No./Description) 
Expression Purified  Protein 
E. coli  P. pastoris
Yield 
(mg/L) 
Aggregation
a Degradation
b
Monospecifc          
1 HVHP428-VTB  S    15.7  No  No 
2 VTB-HVHP428           
3 VTB-CBM2a(m)  S    NA  NA  NA 
4 VTB-CBM2a           
5 VTB-CBM9           
6 CBM2a(m)-VTB  IB         
7 CBM2a-VTB  S    NA  NA  NA 
8 CBM9-VTB           
Bispecific          
9 HVHP428-VTB-CBM2a(m)  NE  S  NA  NA  NA 
10 HVHP428-VTB-CBM2a  NE         
11 HVHP428-VTB-CBM9  NE         
12 CBM2a(m)-VTB-VHV28  S    Low  Yes  Yes 
13 CBM2a-VTB-HVHP428  S    3.8  Yes  Yes 
14 CBM9-VTB-HVHP428  S    7.8  No  Low 
 S = soluble, IB = inclusion bodies, NE = no expression, NA = not attempted. 
 aDetermined by size exclusion chromatography. 
 
bDetermined by SDS-PAGE. 
 
3.2. Functional Characterization of CBM9-VTB-HVHP428 Bispecific Pentamer 
 
To determine whether CBM9-VTB-HVHP428 was capable of specifically binding S. aureus cells 
and cellulose, two assays were performed. Microagglutination of S. aureus with CBM9-VTB-
HVHP428 confirmed that HVHP428 retained its ability to bind protein A when assembled as part of 
the bispecific pentamer (Figure 4A), albeit not as effectively as the monospecific pentamer HVHP428-
VTB. The lowest concentration of CBM9-VTB-HVHP428 to agglutinate S. aureus was 150 nM 
compared to 18.7 nM for HVHP428-VTB. The monospecific pentamer control, HVHP335-VTB, 
which does not recognize S. aureus [26], did not agglutinate cells at any of the concentrations tested. 
In the second assay, mono- and bispecific pentamers were added to Whatman No. 5 filter paper using a 
vacuum manifold and probed with alkaline phosphatase labeled protein A (Figure 4B). We conclude 
that CBM9-VTB-HVHP428 specifically bound to cellulose paper because only a small fraction of 
HVHP428-VTB, when used as a control, bound non-specifically to the paper.  
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CBM9-VTB-HVHP428 
Figure 4. Functional characterization of CBM9-VTB-HVHP428. (A) Agglutination of S. 
aureus (wells without small white dots in the middle) was seen for CBM9-VTB-HVHP428 
with an end limit of 150 nM compared to an end limit of 18.7 nM for the positive control, 
HVHP428-VTB. No agglutination was seen for the negative control, HVLP335-VTB [26]. 
(B) Binding of CBM9-VTB-HVHP428 to cellulose. Serial dilutions of purified CBM9-VTB-
HVHP428 and HVHP428-VTB were applied to Whatman No. 5 filter paper using a vacuum 
manifold. Binding was detected by incubating the paper with alkaline phosphatase-labeled 
protein A.  
  
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
3.3. Detection of S. aureus with CBM9-VTB-HVHP428 Impregnated Filters 
 
To determine if CBM9-VTB-HVHP428 could be used for the detection of S. aureus, cellulose filter 
discs were impregnated with the molecule and S. aureus cells were passed through the discs   
(Figure 5A) with the assistance of a vacuum manifold. HVHP428-VTB-treated and blank filter discs 
(i.e., no protein) were used as negative controls. Following probing with anti-protein A-HRP IgG, it 
was determined that CBM9-VTB-HVHP428 was capable of readily detecting 10
5 cfu/mL of S. aureus 
cells (p = 0.05) and as few as 10
4 cfu/mL (p = 0.1), when compared to control discs containing 
monospecific pentamer (Figure 5B and 5C). Filters alone (i.e., containing no applied protein) did not 
bind S. aureus at any of the concentrations tested (data not shown). Based on these results, bispecific 
fusion proteins containing five CBM domains and five sdAbs appear to retain dual functionality when 
immobilized on cellulose supports. 
CBM9-VTB-HVHP428 
HVHP428-VTB 
HVLP335-VTB 
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HVHP428-VTB 
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Figure 5. Detection of S. aureus with immobilized CBM9-VTB-HVHP428. (A) Schematic 
representation of the CBM9-VTB-HVHP428-based biosensor. (i) Loading of bispecific 
pentamer onto the filter, (ii) S. aureus cells passed over the filter, (iii) HRP labeled anti-
protein A IgG passed over the filter, (iv) the filter moved to 96 well plates, substrate applied, 
and the absorbance read at 450 nm, (v) aerial view of filter after substrate. (B) Photograph of 
experimental filter discs after removal of HRP substrate from a 96 well plate. (C) Plot of 
absorbance A (A450 of CBM9-VTB-HVHP428 impregnated discs) - Ao (A450 of control discs 
with HVHP428-VTB) versus the number of S. aureus colony forming units (cfu) applied to 
each disc. Limit of detection = 10
5 cfu/mL (p = 0.05). Error bars represent standard error of 
the mean (SEM) based on A450 values from two independent experiments with three 
replicates in each.  
 
 
 
 
 
 
 
  
 
 
       
 
 
                
 
 
 
 
 
 
 
 
 
 
4. Discussion 
 
In this work, we set out to develop an immobilization platform for the oriented display of sdAbs 
with high valency and apply this platform for pathogen biosensing. We demonstrated that it is possible 
to make a bispecific fusion protein consisting of a CBM for immobilization on cellulose joined to a 
human sdAb for antigen binding all linked via the VTB subunit. Furthermore, five of these bispecific 
polypeptide chains assemble to make a bispecific pentamer with extremely high antigen and cellulose 
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affinity due to the avidity conferred by its pentameric structure. This work is the first to report the 
expression of functional pentameric CBMs and the first to demonstrate fusion of human sdAbs to 
CBMs.  
Compared to chemical cross-linking of antibodies to solid supports where random orientation and 
steric hindrance can decrease the activity of immobilized ligand [30], CBMs are thought to orient their 
fusion partners away from the immobilization surface, allowing for the biologically active fusion 
partner to access its target substrate or antigen. In this study, we tested three CBMs as either N- or C- 
terminal fusions to HVHP428 and found one molecule, CBM9-VTB-HVHP428, which expressed as a 
soluble, non-aggregating bispecific pentamer in E. coli. Several of our other bispecific pentamers 
containing CBMs and HVHP428 either did not express in E. coli, were insoluble, or were prone to 
both aggregation and degradation. However, we found that fusions containing N-terminal CBMs were 
soluble in E. coli. These results are in agreement with the literature where more than twelve functional 
fusion proteins containing an N-terminal CBM9 affinity tags have been reported [31]. Interestingly, we 
found that fusions containing C-terminal CBMs did not express well in E. coli. While no C-terminal 
CBM9 fusion proteins have been reported, most CBM2a (formerly CBDCex) fusion proteins described 
by other researchers contain the CBM at the C-terminus [27,32].  
The poor expression of C-terminal-containing CBM fusion proteins was somewhat surprising since 
CBMs are naturally found at different positions within the cellulase polypeptide chain, i.e. at the N-
terminal, C-terminal, or between these two termini [24]. Our results indicate that the optimal CBM 
orientation in the recombinant fusion proteins produced here differs from the orientation of the same 
CBM found in nature. This is likely due to the influence of the fusion partner on the global 
conformation of the fusion protein, as non-optimal orientations may expose internal hydrophobic 
residues (causing aggregation and poor solubility), or may negatively affect the activity of one or both 
of the fusion partners, as seen in our agglutination assay results (Figure 4A). Most CBMs rely on 
surface-exposed aromatic residues, such as tryptophan, for cellulose binding [27]. The pentamerization 
of CBM9 within the CBM9-VTB-HVHP428 molecule did not appear to sterically hinder its interaction 
with cellulose, as some or all of the external aromatic residues putatively responsible for binding must 
be sufficiently close enough to the sugar residues to form hydrogen bonds. Previously,   
Linder et al. [33] produced a double cellulose-binding domain fusion protein consisting of two CBMs 
from Trichoderma reesei and found the fusion to bind cellulose with higher affinity than either of the 
CBMs alone. The authors also concluded the double CBMs did not sterically hinder each others’ 
access to the cellulose surface. Elsewhere, an anti-azo red dye llama VHH single-domain antibody 
fusion protein containing two CBMs was found to adhere to cellulose stronger than VHH fusions 
containing a single CBM [35]. Based on the ability of CBM9-VTB-HVHP428 to bind cellulose in our 
assay (Figure 4B), it is assumed that the some or all of the five CBM domains have free access to 
cellulose surfaces.  
In this study we also demonstrated that five HVHP428 sdAbs retained their ability to bind S. aureus 
antigen when expressed as part of the bispecific pentamer. This was not surprising since production of 
pentabody [16] and decabody [25] formats using llama sdAbs resulted in functionally active antibodies 
with higher overall affinities than their monomeric counterparts. Specifically, CBM9-VTB-HVHP428 
was capable of binding S. aureus in solution and when immobilized on cellulose filters. However, the 
lowest concentration of CBM9-VTB-HVHP428 to agglutinate S. aureus in the microagglutination Sensors 2009, 9                  
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assay was significantly higher than that of the control HVHP428 pentamer, which does not contain 
CBM9, indicating the CBM9 fusion may have some detrimental effect on sdAb activity. When CBM9-
VTB-HVHP428 was immobilized on cellulosic filters, HVHP428 retained its ability to bind S. aureus 
cells. This suggests HVHP428 was not buried in the filter; rather, it was orientated to permit binding to 
S. aureus. Collectively, our results indicate that both pentamerized domains (i.e., sdAb and CBM) 
retained dual functionality. These results agree with previous work which showed that llama VHH 
single-domain antibodies retain functionality when fused to CBMs [34,35]. 
The use of recombinant single-domain antibody fragments (i.e., VHH, VH, VL), when fused to 
immobilization domains such as CBMs, is a low-cost biosensing platform that maintains high target 
specificity and affinity. The single-domain nature of the antibodies used in this study was likely 
critical to the successful formation of a functional, bispecific pentamers. As such, one would expect 
more complex recombinant antibody formats (e.g., scFvs) to perform poorly in these multivalent, 
antigen-binding structures due to their vulnerability to intermolecular domain association. 
 
5. Conclusions 
 
In summary, the bispecific molecule produced in this study was simultaneously capable of 
immobilization on cellulose and oriented display of high-avidity human sdAbs for antigen capture. We 
have demonstrated a rapid, near real-time biosensing assay for pathogen detection by immobilizing 
this sdAb-CBM fusion protein on a cheap and abundant support matrix, cellulose, and detected 
pathogen capture with commercially available assay reagents. The strong affinity attachment of the 
biorecognition molecule to the sensing surface is preferable to physical adsorption because of the 
oriented display and the essentially irreversible nature of the attachment. These are important features 
of any bioactive paper-based sensor. We envision that these bispecific pentamers may form the basis 
of an immobilization platform for displaying high valency reagents, such as engineered antibodies and 
enzymes, on paper for applications ranging from blood filtration, to water purification, and pathogen 
detection. Given the demonstrated feasibility of printing microfluidic channels on paper 
surfaces [19,20], it is easy to envision a device in which the test sample is drawn over a surface on 
which the bispecific molecule is immobilized. Following capture of the target pathogen or molecule, a 
suitable amount of the detection reagent could be drawn over the biosensing area on the paper.  
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